Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Chapman

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|September 1, 1994
Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibodyP B Chapman, S D Gillies, A N Houghton, et al.
Journal of Neuroscience Research|January 16, 2010
Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndromeS Usuki, K Taguchi, S A Thompson, et al.
Cytotherapy|January 19, 2008
Antibody response to GD3 ganglioside is independent of NKT cellsJ-E Park, S X Lu, D Y Wu, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Recognition of autoantigens by patients with melanomaA N Houghton, S Vijayasaradhi, B Bouchard, et al.
International Journal of Cancer|April 10, 1995
Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejectionI Hara, H Nguyen, Y Takechi, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of cisplatin and etoposide in patients with metastatic melanomaO Eton, D F Bajorin, P B Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodiesT J Yao, M Meyers, P O Livingston, et al.
Melanoma Research|August 1, 1997
Anti-melanoma effects of R24, a monoclonal antibody against GD3 gangliosideM L Nasi, M Meyers, P O Livingston, et al.
Clinics in Plastic Surgery|August 15, 2000
Systemic chemotherapyV M Klimek, J D Wolchok, P B Chapman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15T Takahashi, P B Chapman, S Y Yang, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|September 1, 1994
Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibodyP B Chapman, S D Gillies, A N Houghton, et al.
Journal of Neuroscience Research|January 16, 2010
Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndromeS Usuki, K Taguchi, S A Thompson, et al.
Cytotherapy|January 19, 2008
Antibody response to GD3 ganglioside is independent of NKT cellsJ-E Park, S X Lu, D Y Wu, et al.
Annals of the New York Academy of Sciences|August 12, 1993
Recognition of autoantigens by patients with melanomaA N Houghton, S Vijayasaradhi, B Bouchard, et al.
International Journal of Cancer|April 10, 1995
Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejectionI Hara, H Nguyen, Y Takechi, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of cisplatin and etoposide in patients with metastatic melanomaO Eton, D F Bajorin, P B Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodiesT J Yao, M Meyers, P O Livingston, et al.
Melanoma Research|August 1, 1997
Anti-melanoma effects of R24, a monoclonal antibody against GD3 gangliosideM L Nasi, M Meyers, P O Livingston, et al.
Clinics in Plastic Surgery|August 15, 2000
Systemic chemotherapyV M Klimek, J D Wolchok, P B Chapman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15T Takahashi, P B Chapman, S Y Yang, et al.
Pageof 5